The Role of Lipoarabinomannan in Mycobacterium tuberculosis

描述（由申请人提供）：结核分枝杆菌是一种主要的人类病原体，在世界范围内造成严重的人类痛苦。作为单一细菌感染导致死亡的主要原因，必须了解生物体的生物学，生理学和致病性。迫切需要改进的诊断、治疗和药理学。M.结核病表现出某些有助于其致病性和建立潜伏感染的潜力的特征。其中，富含脂质的细胞壁在与宿主的相互作用中起着关键作用，是抵御免疫攻击的第一道防线。该探索性项目的主要目的是确定结核杆菌中关键的主要细胞壁组分之一脂阿拉伯甘露聚糖（LAM）的生理作用。以前不可能在整个细胞的背景下研究LAM，因为LAM阴性突变体尚未分离，我们最近表明这是由于其对细菌存活的重要性。虽然不能构建突变体，但我们已经改造了一株M。在另一个实施方案中，本发明提供了一种结核分枝杆菌，其与野生型细胞相比以降低的水平表达LAM生物合成所需的关键酶之一EmbC，其结果是产生更小尺寸的LAM。我们将确定LAM产生的变化对包括乙胺丁醇、DNA损伤剂和活性氧和氮物质在内的广泛化合物的抗性有什么影响。缺乏EmbC在M中是致命的。结核病，但减少表达是可以容忍的。我们将确定如何低EmbC表达可以减少细菌的生存受到损害之前，通过构建一个菌株从一个可控的，可滴定的启动子表达embC。随后，我们将进行表型测定，以确定EmbC耗竭的生理后果。将特别关注合成的LAM的大小和结构以及对破坏剂和应激的抵抗力。产生的数据将提供LAM在细菌细胞中的生理作用的图片，并为进一步研究致病性提供平台。公共卫生相关性：结核分枝杆菌是人类结核病的病原体，结核病是一种毁灭性的传染病，每年造成近200万人死亡，800多万人感染。目前迫切需要新的治疗药物，并增加对疾病过程的了解。该提案旨在增加我们对致病的关键细菌效应子之一的理解，并定义其在细菌生理学中的作用。

DESCRIPTION (provided by applicant): Mycobacterium tuberculosis is a major human pathogen causing significant human suffering worldwide. As the leading cause of death from a single bacterial infection, it is imperative to understand the biology, physiology and pathogenicity of the organism. Improved diagnostics, therapeutics and prophylactics are urgently required. M. tuberculosis exhibits certain features which contribute to its pathogenicity and potential to establish latent infections. Among these, the lipid-rich cell wall plays a critical part in interaction with the host, being the first line of defence against immune attack. The primary aim of this exploratory project is to define the physiological role of one of the critical, major cell wall components, lipoarabinomannan (LAM) in the tubercle bacillus. It has not been possible to study LAM in the context of the whole cell previously, since LAM negative mutants have not been isolated and we have recently shown that this is due to its essentiality for bacterial survival. Although, mutants cannot be constructed, we have engineered a strain of M. tuberculosis which expresses EmbC, one of the key enzymes required for LAM biosynthesis, at a reduced level compared to wild-type cells, the consequence of which is that LAM of a smaller size is produced. We will determine what effect changes in LAM production have on resistance to a wide range of compounds including ethambutol, DNA damaging agents and reactive oxygen and nitrogen species. A lack of EmbC is lethal in M. tuberculosis, but reduced expression is tolerated. We will determine how low EmbC expression can be reduced before bacterial survival is compromised by constructing a strain expressing embC from a controllable, titratable promoter. Subsequently, we will conduct phenotypic assays to determine the physiological consequences of EmbC depletion. Particular attention will be paid to the size and structure of LAM synthesized and resistance to damaging agents and stresses. The data generated will provide a picture of the physiological role of LAM in the bacterial cell and provide a platform for further work investigating pathogenicity. PUBLIC HEALTH RELEVANCE: Mycobacterium tuberculosis is the causative agent of human tuberculosis, a devastating infectious disease, which kills nearly 2 million and infects more than 8 million people each year. There is an urgent unmet need for new therapeutic agents and an increased understanding of the disease process. This proposal aims to increase our understanding of one of the key bacterial effectors of pathogenesis and define its role in bacterial physiology.